Novartis Bioventures Ltd 13D and 13G filings for Forma Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:31 pm Sale | 2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Novartis Bioventures Ltd | 1,757,057 3.710% | -1,234,648 (-41.27%) | Filing |